Biosergen applies to delist shares from Nasdaq First North Growth Market
Biosergen AB said it has applied to delist its shares from the Nasdaq First North Growth Market, conditional upon completion of its merger with Flerie.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.